5 completed, 1 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 5, Unknown 1 |
Follow Asperger Syndrome: new trials by email Literature Review of Asperger Syndrome trials Research Report on Asperger Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD Methylphenidate extended-release liquid formulation - Attention-deficit/Hyperactivity Disorder, Autism Spectrum Disorder | Phase 4 | Completed | Massachusetts General Hospital | 15 | 2014-05-01 | 2024-07-01 |
| An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum Gammaplex 5% - Autism, Autistic Disorder | Phase 4 | Unknown | Isaac Melamed | 30 | 2013-06-01 | 2015-04-16 |
| Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder placebo, extended-release guanfacine - Pervasive Development Disorders | Phase 4 | Completed | Yale University | 62 | 2011-12-01 | 2020-03-31 |
| Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism Milnacipran, Placebo - Autism Spectrum Disorder, Asperger Syndrome | Phase 4 | Completed | Montefiore Medical Center | 10 | 2011-02-01 | 2020-02-27 |
| Atomoxetine, Placebo and Parent Management Training in Autism atomoxetine, Placebo, Parent Management Training - Autism, Pervasive Development Disorder | Phase 4 | Completed | University of Rochester | 128 | 2008-10-01 | 2016-02-04 |
| Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study Risperidone, Magnetic Resonance Spectroscopy - Asperger's Disorder | Phase 4 | Completed | Augusta University | 23 | 2001-11-01 | 2015-01-14 |
Autistic Disorder (4) · Attention Deficit Disorder with Hyperactivity (3) · Child Development Disorders, Pervasive (3) · Autism Spectrum Disorder (2) · Social Skills (1) · Spasm (1)
Mental Disorders (6) · Neurodevelopmental Disorders (6) · Autism Spectrum Disorder (4) · Attention Deficit and Disruptive Behavior Disorders (3) · Child Development Disorders, Pervasive (3) · Behavior (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Social Behavior (1)
Atomoxetine Hydrochloride (1) · Guanfacine (1) · Magnetic Resonance Spectroscopy (1) · Milnacipran (1) · Risperidone (1)
Augusta University (1) · Isaac Melamed (1) · Massachusetts General Hospital (1) · Montefiore Medical Center (1) · University of Rochester (1) · Yale University (1)
United States (6)
Benjamin Handen, PhD (1) · Bryan King, MD (1) · Christopher McDougle, MD (1) · Donna L Londino, MD (1) · Eric Hollander, MD (1) · Gagan Joshi, MD (1) · Isaac Melamed, MD (1) · James Dziura, MPH, PhD (1) · James McCracken, MD (1) · Jeffrey L Rausch, MD (1) · Lawrence Scahill, MSN, PhD (1) · Michael Aman, PhD (1) · Tristram Smith, PhD (1)
PMID 37811711, PMID 20377705, PMID 26506581, PMID 27663942, PMID 29022125, PMID 29694241, PMID 31607204
R01MH083707 (1)